{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:48Z","timestamp":1787026968740,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01598","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:23:45Z","timestamp":1599092625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?"],"prefix":"10.3389","volume":"10","author":[{"given":"Jiali","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0564-x","article-title":"The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.","volume":"11","author":"Xu","year":"2018","journal-title":"J Hematol Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1080\/10428190290033323","article-title":"Dose and schedule effect of G-GSF for stem cell mobilization in heal- thy donors for allogeneic transplantation.","volume":"43","author":"Kr\u00f6ger","year":"2002","journal-title":"Leuk Lymphoma."},{"key":"B3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1365-2141.2006.06223.x","article-title":"Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.","volume":"134","author":"Ings","year":"2006","journal-title":"Br J Haematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the american society for blood and marrow transplantation.","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cpdd.269","article-title":"Confirmation of biosimilarity in a harmacokinetic\/pharmacodynamic study in healthy volunteers for an analytically highly similar pegfilgrastim.","volume":"5","author":"Desai","year":"2016","journal-title":"Clin Pharmacol Drug Dev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00001813-200304000-00002","article-title":"Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients.","volume":"14","author":"Molineux","year":"2003","journal-title":"Anticancer Drugs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.exphem.2005.08.003","article-title":"Single-dose pegfilgrastim for the mobilization of allogeneic CD34+peripheral blood progenitor cells in healthy family and unrelated donors.","volume":"90","author":"Kroschinsky","year":"2005","journal-title":"Haematologica."},{"key":"B8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbmt.2006.03.001","article-title":"Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.","volume":"12","author":"Hill","year":"2006","journal-title":"Biol Blood Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12185-014-1507-0","article-title":"Successful peripheral blood stem cell mobilization using pegfilgrastim in allogeneic stem cell transplantation.","volume":"99","author":"Chanswangphuwana","year":"2014","journal-title":"Int J Hematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbm-","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute gvhd international consortium.","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report.","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/trf.14426","article-title":"Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin\u2019s lymphoma: a randomized Phase 3 study.","volume":"58","author":"Zhu","year":"2017","journal-title":"Transfusion."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.","volume":"10","author":"Xu","year":"2017","journal-title":"J Hematol Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/bmt.2013.224","article-title":"Long-term outcome of HLA haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy.","volume":"49","author":"Gao","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bcmd.2009.02.005","article-title":"HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: Long-term comparison with HLA-identical sibling transplantation.","volume":"43","author":"Chen","year":"2009","journal-title":"Blood Cells Mol Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbmt.2008.11.029","article-title":"Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.","volume":"15","author":"Chen","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0186-5","article-title":"Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.","volume":"8","author":"Gao","year":"2015","journal-title":"J Hematol Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.bmt.1704702","article-title":"Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.","volume":"35","author":"Steidl","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/s0301-472x","article-title":"A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans.","volume":"27","author":"Molineux","year":"1999","journal-title":"Exp Hematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jca.20082","article-title":"Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).","volume":"21","author":"Martino","year":"2006","journal-title":"J Clin Apher."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1537-2995.2002","article-title":"Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.","volume":"42","author":"De La Rubia","year":"2002","journal-title":"Transfusion."},{"key":"B22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.leu.2402909","article-title":"Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.","volume":"17","author":"Mohty","year":"2003","journal-title":"Leukemia."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1080\/10428190903085944","article-title":"Optimizing the CD34+ cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.","volume":"50","author":"Mehta","year":"2009","journal-title":"Leuk Lymphoma."},{"key":"B24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.transci.2007.08.002","article-title":"Mobilization of peripheral blood stem cells.","volume":"37","author":"Arslan","year":"2007","journal-title":"Transfus Apher Sci."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014786","article-title":"G-CSF-induced severe thrombocytopenia in a healthy donor: a rare case report.","volume":"98","author":"Lu","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/sj.leu.2403753","article-title":"Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes.","volume":"19","author":"Hern\u00e1ndez","year":"2005","journal-title":"Leukemia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00277-002-0553-5","article-title":"Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multi centers tudy.","volume":"81","author":"Beelen","year":"2002","journal-title":"Ann Hematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1046\/j.1537-2995.1996.36796323058.x","article-title":"Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.","volume":"36","author":"Stroncek","year":"1996","journal-title":"Transfusion."},{"key":"B29","article-title":"Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.","volume":"91","author":"Nuamah","year":"2006","journal-title":"Haematologica."},{"key":"B30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ajh.10434","article-title":"Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.","volume":"74","author":"Hunter","year":"2003","journal-title":"Am J Hematol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130413","article-title":"A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD.","volume":"22","author":"Li","year":"2019","journal-title":"JCI Insight."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1182\/blood-2003-08-2864","article-title":"Donor treatment with pegylated G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance.","volume":"103","author":"Morris","year":"2004","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1182\/blood-2005-10-4299","article-title":"Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?","volume":"107","author":"Morris","year":"2006","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1172\/JCI25249","article-title":"NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.","volume":"115","author":"Morris","year":"2005","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:23:46Z","timestamp":1599092626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":34,"alternative-id":["10.3389\/fonc.2020.01598"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01598","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"article-number":"1598"}}